Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578409 · ClinicalTrials.gov registry record
Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 758
- Enrollment target
NCT00578409: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00578409 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 758 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00578409 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 758 participants
- Enrollment target
Study Summary
We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated machine vision based image analysis of H\&E stained tumor tissue developed at Aureon Biosciences,and molecular biomarker studies (25 markers) determined by immunohistochemistry on tissue microarrays prepared from paraffin-embedded tumor.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 758 participants |
| Start Date | 2004-05 |
| Est. Completion | 2010-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00578409
The ClinicalTrials.gov registry entry for NCT00578409 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 758 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00578409 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00578409 about?
NCT00578409 is a clinical study titled "Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data". We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated machine vision based image analysis of H\&E stained tumor tissue developed at Aureon Biosciences,and molecular bi...
What is the current status of trial NCT00578409?
This trial is currently completed. The enrollment target is 758 participants. The study started on 2004-05. Estimated completion is 2010-04.
Who is sponsoring clinical trial NCT00578409?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.